ROSEN, NATIONAL TRIAL COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline - AQSTPRNewsWire • 03/18/21
AQST INVESTOR LAWSUIT DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Against Aquestive Therapeutics, Inc.GlobeNewsWire • 03/17/21
AQST DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Aquestive Therapeutics, Inc. – AQSTGlobeNewsWire • 03/16/21
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aquestive Therapeutics, Inc. (AQST)PRNewsWire • 03/16/21
AQST Investor Notice: Rosen, A Leading Investor Rights Law Firm, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline - AQSTNewsfile Corp • 03/13/21
AQST Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Aquestive Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the FirmGlobeNewsWire • 03/12/21
Aquestive Therapeutics, Inc. (AQST) CEO Keith Kendall on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/10/21
AQST Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Aquestive Therapeutics, Inc. Investors of Class Action and Encourages Shareholders to Contact the FirmNewsfile Corp • 03/10/21
ROSEN, A TOP RANKED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline – AQSTGlobeNewsWire • 03/10/21
Aquestive Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 03/09/21
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline – AQSTBusiness Wire • 03/08/21
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Aquestive Therapeutics, Inc. (AQST) InvestorsBusiness Wire • 03/08/21
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – AQSTGlobeNewsWire • 03/06/21
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmPRNewsWire • 03/05/21
SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Aquestive Therapeutics, Inc.– AQSTGlobeNewsWire • 03/05/21
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Aquestive Therapeutics, Inc. (AQST) InvestorsBusiness Wire • 03/05/21
Aquestive Therapeutics to Host Investor & Analyst Virtual Epinephrine Drug Delivery R&D Event on March 25 at 9:00 a.m. ETGlobeNewsWire • 03/05/21
SHAREHOLDER ALERT: Robbins LLP Announces That Aquestive Therapeutics, Inc. (AQST) is Being Sued for Misleading ShareholdersBusiness Wire • 03/04/21
The Law Offices of Frank R. Cruz Announces Investigation of Aquestive Therapeutics, Inc. (AQST) on Behalf of InvestorsBusiness Wire • 03/04/21
AQUESTIVE THERAPEUTICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP notifies investors that a securities class action lawsuit has been filed in the United States District Court for the District of New JerseyGlobeNewsWire • 03/04/21
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aquestive Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 03/04/21
Notice of Lead Plaintiff Deadline for Shareholders in the Aquestive Therapeutics, Inc. Class Action LawsuitBusiness Wire • 03/04/21
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline - AQSTPRNewsWire • 03/04/21
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Aquestive Therapeutics, Inc. (AQST) on Behalf of InvestorsBusiness Wire • 03/03/21
